Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
Thursday might have felt like a Monday to quite a few folks around Dallas County and Selma. That is due to having the Martin Luther King Jr. holiday on Monday and then having a couple of snow days ...
Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...
The pumpkins are out and the cider is hot over at Coolspring Corn Maze in Mercer County - and this year plan to include everyone in the fun - including those with sensory needs. The maze is ...